RSV vaccine remains effective against distinct viral variants

GSK's Arexvy vaccine for RSV can remain effective against a range of variants and produces strong antibody responses against distinct viral strains.

Related Keywords

Australia , Anna Frank , Lionel Sacconnay , , Science Translational Medicine , Adult Respiratory Syncytial Virus , Vaccine , Mask , Arexvy , Respiratory Syncytial Virus , Rsv , Drtd , Svpref3 As01 , Adjuvant , Resvi 006 , Svpref3 ,